Chromosome 14 houses a mutation in gene NFKBIA (NFKB inhibitor alpha). Classify its clinical impact — is it pathogenic or benign, and what disease does it lead to if any?
Pathogenic; Ectodermal dysplasia and immunodeficiency 2